The diterpenoids carnosol (CS) and carnosic acid (CA) from Salvia spp. exert prominent anti-inflammatory activities but their molecular mechanisms remained unclear. Here we investigated the effectiveness of CS and CA in inflammatory pain and the cellular interference with their putative molecular targets.
Introduction
Diterpenoids are secondary metabolites found in higher plants, fungi, and marine organisms, and they are known to display multiple biological activities (Giamperi et al., 2012; Zhao et al., 2014) . The anti-inflammatory and analgesic characteristics of some diterpenoids -especially those isolated from plants -have been intensively described, and mainly interfere with the multiple signaling pathways that are deregulated during inflammation and inflammatory pain syndrome, including NF-κB (Salminen et al., 2008) , p38-MAPK (Kundu et al., 2006) and phosphatidylinositol-3K (Johnson, 2011) .
Among the analgesic diterpenoids, much attention has recently been pointed on carnosol (CS) and carnosic acid (CA; Figure 1 ), which suppress cyclooxygenase (COX)-2, interleukin-1β, and tumor necrosis factor-α expression as well as leukocyte infiltration in inflamed tissues (Mengoni et al., 2011; Zhao et al., 2015) and regulate the levels of the inflammatory MMP-9 and monocyte chemoattractant protein-1 (MCP-1) in cell migration (Chae et al., 2012) . In addition, molecular targets of CS and CA within the eicosanoid biosynthetic pathways have been revealed, including 5-lipoxygenase (5-LO), the key enzyme in the biosynthesis of pro-inflammatory leukotrienes (Laughton et al., 1991; Poeckel et al., 2008) , COX enzymes that initiate prostaglandin (PG) synthesis (Laughton et al., 1991) , and microsomal PGE 2 synthase (mPGES)-1 (Bauer et al., 2012) which is the terminal enzyme in pro-inflammatory PGE 2 formation.
Contingently, it has been found that Salvia species (spp.) (Labiateae) containing these diterpenoids (Bruna et al., 2006; Villa et al., 2009) , could act as a mild analgesic (Mirjalili et al., 2006; Raal et al., 2007) . Recent investigations have demonstrated the anti-nociceptive potential of Salvia officinalis extract and its isolated compound CS in different in vivo models of inflammation (Rodrigues et al., 2012) . Subsequently, it has been validated that the hydroalcoholic extract of Salvia officinalis and its constituent CS inhibit formalin-induced pain and inflammation in mice (Emami et al., 2013) .
Furthemore, increasing interest worldwide has been expressed within recent years in the use of bioactive compounds originally present in plants to provide health-care products (Miyata, 2007; Di Lorenzo et al., 2013) . In this context, different plants belonging to Salvia spp. offer considerable potential for the development of healthier foods. Overall, most of their bioactive components, in addition to other important nutritional components such as vitamins and minerals, exhibit anti-inflammatory and anti-oxidative properties that could provide a rational for the prevention and/or treatment of inflammatory complications (Maione et al., 2015b) .
In light of the ethnobotanical use of Salvia spp. (and their potential application as nutraceuticals) wherein the main constituents are diterpenoids, here we have evaluated potential analgesic activities of the CS and CA in the treatment of pain and inflammation. In more detail, we have used in vivo models of inflammatory and mechanical pain, and successively we have investigated the cellular interference with their molecular targets taking into account the key enzymes involved in the arachidonic acid cascade as mPGES-1 and 5-LO.
Methods

In vivo procedures
Animals. All animal care and experimental procedures were approved by the local animal care office (Service for Biotechnology and Animal Welfare of Istituto Superiore di Sanità) and were carried out to minimize the number of animals used and their suffering. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . CD-1 male mice (10-14 weeks of age, 25-30 g of weight) were purchased from Charles River (Milano, Italy) and kept in animal care facility under controlled temperature, humidity and light/dark cycle, and with food and water ad libitum. A total of 66 animals were used for the experiments described here. 
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Induction and assessment of carrageenan-induced hyperalgesia. Acute inflammation was induced in the right hind paw by injecting subcutaneously (s.c.) 50 μl of freshly prepared solution of 1% carrageenan. The left paw received 50 μl of saline, which served as control. The response to inflammatory pain was determined by measuring the mechanical nociceptive pressure by the paw pressure test via a commercially available analgesiometer (Ugo Basile, Italy). The apparatus was set up to apply a force of 0-250 g, increasing from zero. The nociceptive threshold was taken as the end point at which mice vocalized or struggled vigorously (Randall and Selitto, 1957) . CS and CA were administrated subcutaneously (s.c.) into the dorsal hind paw of the mice in a dose-dependent manner (1-100 μg 20 μl À1 ) 30 min before 1% carrageenan (50 μl; s.c.) into the dorsal hind paw of the mice, and the pressure threshold was observed at 0.5, 1, 3, and 4 h. The time selection was made based on the preliminary studies. A change in the hyperalgesic state was calculated as a percentage of the maximum possible effect (% MPE) from the formula: [(P 2 -P 1 )/(P 0 -P 1 ) × 100], where P 1 and P 2 were the pre-and post-drug paw withdrawal thresholds respectively, and P 0 was the cut-off (250 g).
Formalin test. The procedure used has been previously described (Colucci et al., 2008) . Subcutaneous injection of a dilute solution of formalin (1%, 20 μl/paw) into the mice hind paw evokes nociceptive behavioral responses, such as licking, biting the injected paw or both, which are considered indices for pain. The nociceptive response shows a biphasic trend, consisting of an early phase occurring from 0 to 10 min after the formalin injection, due to the direct stimulation of peripheral nociceptors, followed by a late prolonged phase occurring from 20 to 40 min that reflects the response to inflammatory pain. In light of the results for carrageenan-induced hyperalgesia, we have selected the dose of 100 μg to test the effect of the two diterpenoids on the formalin test. During the test, the mouse was placed in a Plexiglas observation cage (30 × 14 × 12 cm), 1 h before the formalin administration to allow it to acclimatize to its surroundings. The total time (s) that the animal spent licking or biting its paw during the formalininduced early and late phase of nociception was recorded. CS and CA were administrated subcutaneously (s.c.) (100 μg/20 μl) 30 min before formalin injection (20 μl; s.c.).
Activity assay for human recombinant 5-LO. Human recombinant 5-LO was expressed in Escherichia coli (E. coli BL21 (DE3)) cells and partially purified by affinity chromatography using an ATP-agarose column as described . Semi-purified 5-LO (1.6 ± 0.2 μg 5-LO products per μg protein) was diluted in PBS containing EDTA (1 mM) and ATP (1 mM) to a concentration of 0.5 μg mL À1 and immediately pre-incubated with the test compounds (1 μl in DMSO; final DMSO concentration: 0.1%) for 10 min at 4°C. Samples were pre-warmed for 30 s at 37°C, and 5-LO product formation was initiated by addition of CaCl 2 (5 μl; in water) and arachidonic acid (5 μl; in methanol) to final concentrations of 2 mM and 20 μM, respectively. The reaction was stopped after 10 min at 37°C by addition of 1 ml ice-cold methanol. Formed 5-LO metabolites (all-trans isomers of LTB 4 and 5-hydro(pero)xy-6,8,11,14-eicosatetraenoic acid (5-H(P)ETE)) were extracted and an aliquot of 50 μl analyzed by reversed phase-HPLC (RP-HPLC) as described (Koeberle et al., 2009) . Data were normalized to the vehicle control to avoid variations independent of test compounds.
Activity assay for human mPGES-1. Microsomal preparations of interleukin-1β-treated A549 (Homo sapiens lung carcinoma) cells were prepared as previously described (Koeberle et al., 2008) and used as source for mPGES-1 (Koeberle et al., 2008) . Microsomes (2.5-5 μg total protein) in 50 μl potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione were pre-incubated with the test compounds (1 μl in DMSO; final DMSO concentration: 2%) for 15 min at 4°C. The reaction was started by addition of PGH 2 (50 μl in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione; final concentration: 20 μM) and terminated after 1 min by addition of stop solution (100 μl; 40 mM FeCl 2 , 80 mM citric acid and 10 μM of 11β-PGE 2 as internal standard). PGE 2 was extracted and analyzed by reversed phase-HPLC as described (Koeberle et al., 2008) . Data were normalized to the vehicle control to avoid variations independent of test compounds.
Blood cell isolation and cultivation of cell lines. Human neutrophils and monocytes were freshly isolated from peripheral blood obtained at the Institute for Transfusion Medicine of the University Hospital Jena (Germany) as described (Schaible et al., 2013b) . In brief, leukocyte concentrates were obtained from venous blood by centrifugation. Cells were isolated by dextrane sedimentation and centrifugation on Histopaque-1077 cushions (SigmaAldrich (Deisenhofen, Germany). Erythrocytes were lysed under hypotonic conditions and neutrophils were recovered by centrifugation. Monocytes were isolated from the fraction of peripheral blood mononuclear cells (PBMC) by adherence to culture flasks. Washed cells were finally resuspended in PBS pH 7.4 plus 1 mM CaCl 2 containing 1 mg/ml glucose (neutrophils) or monocyte medium (RPMI 1640 medium
Figure 1
Molecular structures of CS (1) and CA (2). Also shown, as compound 3, is the structure of the inhibitor of mPGES
containing L-glutamine (2 mM) and penicillin/streptomycin (100 U/ml and 100 μg/ml, respectively) supplemented with FCS (5%, v/v; monocytes).
Analysis of the eicosanoid profile of activated human neutrophils and monocytes. Neutrophils (5 × 10 6 cells ml À1 ) in PBS pH 7.4 plus 1 mM CaCl 2 containing 1 mg·mL À1 glucose were pre-incubated with test compounds (1 μl in DMSO; final DMSO concentration: 0.1%) for 10 min and then treated with 2.5 μM Ca 2+ ionophore A23187 (1 μl in methanol; final methanol concentration: 0.1%) for 15 min at 37°C. Monocytes (1.2 × 106 cells ml À1 ) in monocyte medium supplemented with FCS (5%, v/v) were pre-incubated with test compounds (1 μl in DMSO; final DMSO concentration: 0.1%) for 10 min and then treated with 2 μg/ml LPS from E. coli 0127:B8 (Sigma-Aldrich, Deisenhofen, Germany) for 24 h. Eicosanoid formation was stopped and eicosanoids extracted as described (Schaible et al., 2013a) .
Reversed phase liquid chromatography and mass spectrometry. Eicosanoids (in 3 μl sample) were separated on an Acquity UPLC (Ultra Performance Liquid Chromatography) BEH C18 column (1.7 μm, 2.1 × 50 mm, Waters, Milford, MA) using an Acquity TM UPLC system (Waters, Milford, MA, USA) as previously described Schaible et al., 2013a) . The chromatography system was coupled to a Quadrupole Ion Trap (QTRAP) 5500 Mass Spectrometer (AB Sciex, Darmstadt, Germany) equipped with an electrospray ionization source. Eicosanoids were quantified by multiple reaction monitoring in the negative using a previously reported method with a lower limit of detection of 150 to 600 pg ml À1 and linear quantification range up to 200 ng ml À1 . Automatic peak integration was performed with ANALYST 1.6 software (Sciex, Darmstadt, Germany) using IntelliQuan default settings. Data were normalized on the internal standard PGB 1 and are given as relative intensities.
Docking studies. The chemical structures of CS and CA were built with MAESTRO BUILD PANEL (version 9.6) (Maestro, 2013) and processed with LIGPREP (version 2.8) (LigPrep, 2013) , generating all the possible tautomers, protonation states at a pH of 7.4 ± 1.0, and finally minimized using optimized potentials for liquid simulations (OPLS, 2005) force field. The three-dimensional structures of the protein targets mPGES-1 (Li et al., 2014) and 5-LO (Gilbert et al., 2011) (PDB code: 4BPM and 3O8Y respectively) were prepared with the Schrödinger Protein Preparation Wizard (Maestro, 2013) . The water molecules were removed, all hydrogens were added and bond orders were assigned. Molecular docking studies of these two compounds, with mPGES-1 as target, were performed using standard precision (SP) and extra precision mode (XP) mode (Glide version 6.1) Halgren et al., 2004; Friesner et al., 2006; Maestro, 2013) . We chose coordinates and dimensions along x, y, z axes of the grid related to the site of presumed pharmacological interest (centered at 10.0557 (x), 16.6230 (y), 45.7128 (z), with inner box dimensions of 16 x 26 x 22 and outer box dimensions of 27 x 37 x 33). Following the same procedure for 5-LO, extra-precision output results were analyzed, and best-scoring poses were used as input to perform an induced-fit docking for 5-LO (Sherman et al., 2006a; Sherman et al., 2006b; Induced, 2013) , choosing PHE177, TYR181, HIS367, LEU368, HIS372, LEU373, ILE406, LEU414, HIS550, ASN554, LEU607, ILE673 residues as flexible and the rest of the protein as rigid. We set a grid inner box size of 10 Å and grid outer box of 20 Å, saving 30 conformations as maximum number of binding modes. Illustrations of the 2D and 3D models were generated using Maestro (version 9.6) (Maestro, 2013) .
Statistical analysis
The results obtained were expressed as the mean ± SEM. Statistical analysis was performed by using one-way analysis of variance (ANOVA) followed by Dunnett's or Tukey's post hoc test. In some cases, one sample t-test was used to evaluate significance against the hypothetical zero value. Statistical analysis was performed by using GRAPHPAD PRISM 4.0 software (San Diego, CA, USA). Data were considered statistically significant when a value of P < 0.05 was achieved. The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) .
Materials
CS and CA were purchased from Sigma-Aldrich (Deisenhofen, Germany). Test compounds were dissolved in DMSO, stored in the dark at À20°C, and freezing/thawing cycles were kept to a minimum. Carrageenan was obtained from SigmaAldrich Co. (Milan, Italy). Unless otherwise stated, all the other reagents were from Carlo Erba Reagents (Milan, Italy).
Results
Effect of CS and CA on carrageenan-induced hyperalgesia in mice
We determined the analgesic efficacy of CS and CA in carrageenan-induced hyperalgesia, a well-established murine pain model (Morris, 2003) . As shown in Figure 2 , both CS and CA displayed significant anti-nociceptive effects 4 h after
Figure 2
Effect of CS and CA acid in the carrageenan-induced hyperalgesia model. CS and CA were injected s.c. (1, 30 or 100 μg in 20 μL), 30 min before injection of 1% carrageenan (50 μL; s.c.) into the same hind paw of mice. Paw withdrawal was recorded 4 h after carrageenan administration. The results obtained are expressed as the mean ± SEM; n = 6. *P < 0.05; significantly different from vehicle control (V); one-way ANOVA with Dunnett's post hoc test.
injection of carrageenan, when administered at a high dose (100 μg/paw). The anti-hyperalgesic effect of CS was protracted even at a dose of 30 μg/paw (43.00±5.13 vs 66.33 ±5.89; P<0.01). No significant effects were observed for the diterpenoids at a dose of 1 μg/paw (Figure 2 ).
Effect of CS and CA on formalin-induced pain in mice
As shown in Figure 3 , the s.c. administration of CS and CA increased the nociceptive threshold in the formalin-induced pain model in mice. Note that CS and CA significantly inhibited the pain response in the paw only in the late phase (302.6±39.50 vs 96.66±24.55; P<0.001 and 296.66±51.75 vs 112.00±23.25; P<0.001 for CS and CA respectively), when administered at the high dose (100 μg/paw).
Effect of CS and CA on the eicosanoid profile of activated human neutrophils and monocytes
To shed light on the molecular mechanisms for the analgesic action of CS and CA in inflammatory pain, we investigated their effects on the pro-inflammatory eicosanoid network. First, we confirmed that CS and CA potently inhibit 5-LO (CS: IC 50 = 0.3; CA: IC 50 = 0.8 μM; Figure 4A ) and mPGES-1 (CS: IC 50 = 10.9; CA: IC 50 = 14.0 μM; Figure 4B ), two key enzymes involved in inflammatory pain, in cell-free assays, as previously described (Poeckel et al., 2008; Bauer et al., 2012) .
Then, we analyzed the eicosanoid profile of activated immune cells using ultraperfomance liquid chromatographycoupled with electrospray ionization (ESI) tandem mass spectrometry (UPLC-MS/MS) analysis. Human freshly isolated neutrophils were pre-treated with CS and CA (3 to 30 μM), and then stimulated with Ca 2+ -ionophore A23187 to induce eicosanoid formation. As expected, both CS and CA efficiently suppressed the generation of 5-LO products derived from arachidonic acid (LTB 4 , LTB 4 isomers, 5-hydroxyicosatetraenoic acid (5-HETE), 5-oxo-eicosatetraenoic acid (5-oxo-ETE), 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid (5,12-DiHETE), 5, 15-dihydroxyeicosatetraenoic acid (5,15-DiHETE), and lipoxin (Lx)A 4 and isomers), eicosatrienoic acid (5-hydroxyeicosatrienoic acid (5-HETrE)) and eicosapentaenoic acid (5-hydroxy-eicosapentaenoic acid (5-HEPE) in neutrophils. In these assays, CS was more potent than CA, except for inhibition of LTB 4 and 5-HEPE formation ( Figure 5A and Supporting Information Figure S1A ). To access the effect of CS and CA on the prostanoid profile, we induced the expression of COX-2 and mPGES-1 and concomitant formation of prostanoids in human blood monocytes by LPS. CS and CA (3 to 30 μM) inhibited the formation of COX-derived eicosanoids (PGE 2 , TxB 2 , PGF 2α , 11-hydroxy-5,8,12,14-eicosatetraenoic acid (11-HETE),
Figure 3
Effect of CS and CA in the formalin-induced pain model. CS and CA were injected s.c. at a single dose (100 μg in 20 μL), 30 min before formalin injection (20 μL; s.c.). Early, licking activity recorded from 0 to 10 min after formalin administration; Late, licking activity recorded from 15 to 40 min after formalin administration. The results obtained are expressed as the mean ± SEM; n = 6. **P < 0.05; significantly different from vehicle control (V); one-way ANOVA with Dunnett's post hoc test.
Figure 4
Effect of CS and CA on 5-LOX (A) and mPGES-1 activity (B). Residual activities (% of control) are shown as mean ± SEM of single determinations obtained in five (A) and three (B) independent experiments. A, *P < 0.05; significantly different from vehicle control; one way ANOVA with Tukey HSD post hoc tests.
Anti-inflammatory response of CA and CS BJP 12-hydroxyheptadecatrenoic acid (12-HHT), PGE 1 , and TxB 1 ) with preference for mPGES-1 products (PGE 2 and PGE 1 ; Figure 5B and Supporting Information Figure S1B ). Differences in the potency between CS and CA were not observed, except for TxB 1 , whose formation was more potently inhibited by CS compared to CA ( Figure 5B and Supporting Information Figure S1B ).
Besides 5-LO product formation, CS and CA also suppressed the formation of distinct lipid mediators derived from 15-LO and 12-LO in activated immune cells ( Figure 5 and Supporting Information Figure S1 ). Thus, CS inhibited 12-hydroxyeicosatetraenoic acid (12-HETE) formation in neutrophils comparable to 5-LO product formation while the production of 12-hydroxyeicosatetraenoic acid (12-HEPE) and 15-hydroxyicosatetraenoic acid (15-HETE) was less potently suppressed ( Figure 5A ). In contrast, CA did not dissect between inhibition of 5-LO and 12/15-LO products in neutrophils. In LPS-activated monocytes, both CS and CA rather induced 12-HETE and 12-HEPE formation, while 15-HETE was equipotently inhibited compared to 5-LO product formation, and 15-hydroxyeicosatrienoic acid (15-HETrE) formation was less potently suppressed ( Figure 5B ). Taken together, our results indicate that 5-LO and mPGES-1 are primary targets of CS and CA which shape the eicosanoid profile of activated innate immune cells.
Molecular docking studies of CS and CA
Our in silico studies are focused on mPGES-1 and 5-LO. Functionally, mPGES-1 is mainly associated to COX-2 and the induction of these two enzymes by pro-inflammatory cytokines leads to an outpouring of PGE 2 production by inflammatory cells.
Interaction of CS and CA on mPGES-1 binding sites
In order to propose a binding mode of CS and CA with the catalytic domain of mPGES-1, we used herein for docking calculations the crystal structures of mPGES-1 in complex with GSH and the inhibitor 2-[[2,6-bis(chloranyl)-3-[(2,2-dimethylpropanoylamino)methyl]phenyl]amino]-1-methyl-6-(2-methyl-2-oxidanyl-propoxy)-N-[2,2,2-tris(fluoranyl)ethyl]benzimidazole-5-carboxamide, (shown as compound 3 in Figure 1) ; (Li et al., 2014 ) (PDB code: 4BPM). For our analysis, we referred to the binding mode of 3 which interacts with three equivalent active site cavities located at the membrane-spanning region of each monomer interface. In more detail, we analyzed the three-dimensional model ( Figure 6 ) and observed an extended set of polar and Figure 5 Effect of CS and CA on eicosanoid formation in activated human neutrophils (A) and monocytes (B). A, Neutrophils were pre-incubated with vehicle (DMSO) or test compounds for 10 min before eicosanoid formation was initiated by A23187 (2.5 μM). B, Monocytes were pre-incubated with vehicle (DMSO) or test items and then stimulated with LPS for 24 h. Heatmaps were prepared using Gene-E 3.0 (Broad Institute) and show residual activities (percentage of vehicle control) as mean of single determinations obtained in three (A) and five (B) independent experiments. Red indicates a relative increase and blue a decrease of eicosanoid levels. 5-LOX products: LTB 4 , trans/epi-trans-LTB 4 , 5-oxo-HETE, 5,12-DiHETE, 5,15-DiHETE, LXA 4 /isomers, 5-HETrE, 5-HEPE; 12/15-LOX products: 12-HETE, 12-HEPE, 15-HETE, 15-HETrE, 5,12-DiHETE, 5,15-DiHETE, LXA 4 /isomers; COX products: PGE 2 , PGE 1 , TxB 2 , TxB 1 , PGF 2α , 11-HETE, 12-HHT; mPGES-1 products: PGE 2 , PGE 1 .
Figure 6
Superimposition of the inhibitor, compound 3, co-crystallized (blue) and calculated (light pink) with mPGES-1 (A). 2D panels of calculated interactions of compound 3 in mPGES-1 binding site (B). Positive charged residues are coloured violet, negative charged residues are coloured red, polar residues are coloured light blue, and hydrophobic residues are coloured green. The π-π stacking interactions are indicated as green lines, and H-bond (side chain) are reported as dotted pink arrows. Neutral histidine with hydrogen on the δ nitrogen is shown as HID, and neutral histidine with hydrogen on the ε nitrogen is shown as HIE.
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hydrophobic interactions of 3 with the key residues responsible for the catalytic activity of the investigated protein (A:ARG126, A:SER127, and A:THR131). In particular, 3 adopts a peculiar shape in the binding site, and this is mainly due to a strong edge-to-face πÀπ interaction between its dichlorophenyl moiety and the phenyl group in the side chain of C:PHE44 and with C:HIS53 (Figure 6 ). The first step of our study is represented from the validation of the model, which was performed by molecular docking (Glide Software) Halgren et al., 2004; Friesner et al., 2006) of 3 with mPGES-1 catalytic domain. As shown in Figure 6 , our calculated model well reproduces the crystal binding mode of 3, where the majority of interactions are respected. After this step of validation, we performed molecular docking study of CS and CA with the enzyme.
CS and CA are accommodated in the same pocket of 3 (Figure 7) , establishing good interactions with receptor counterpart (Sjogren et al., 2013; Li et al., 2014; Luz et al., 2015) . CS establishes fundamental hydrophobic, electrostatic and π-π interactions namely with ARG38, PHE44, ARG52, HIS53 of chain C, and ARG126, PRO124, SER127, THR131 of chain A ( Figure 7C ), in analogy to the co-crystallized ligand. Moreover, it makes interactions with GLY35, LEU39, ASP49 of the chain C, and ALA123 of the chain A ( Figures 7A and C) . On the other hand, CA shows the same pattern of key hydrophobic and π-π interactions (see above), and hydrogen bond between the carboxyl group and ARG52 (Figures 7B and D) .
Interaction of CS and CA on 5-LO binding sites
Regarding the 5-LO enzyme, the induced fit docking approach was used to simulate and study the interactions of CS and CA with the residues that belong to the active site close to the catalytic iron of this enzyme (Gilbert et al., 2011) . The analysis of the most representative docking poses of CS in the ligand binding site reveals a better accommodation with respect to CA as it establishes key interactions with Figure 7 3D models of CS (A) (coloured by atom types: C orange, O red, polar H white) and CA (B) (coloured by atom types: C yellow, O red, polar H white) in the binding site of mPGES-1 with GSH (coloured by atom types: C green, O red, polar H white). Residues in the active site are represented in tubes (coloured by atom types: C grey, N blue, O red, H white). 2D panels represent the interactions between CS (C), CA (D) and the residues of mPGES-1 binding site. Positive charged residues are coloured violet, negative charged residues are coloured red, polar residues are coloured light blue, hydrophobic residues are coloured green. The π-π stacking interactions are indicated as green lines, and H-bonds (side chain) are reported as dotted pink arrows. Neutral histidine with hydrogen on the δ nitrogen is shown as HID, and neutral histidine with hydrogen on the ε nitrogen is shown as HIE.
PHE177, TYR181, LEU368, ILE406, ASN407, LEU414, LEU420, PHE421, HIS432, and LEU607 ( Figure 8A ). Moreover, it makes two hydrogen bonds with GLN363 and the carbonyl oxygen coordinates the metal ( Figure 8C ). CA shows a flipped binding mode with respect to CS maintaining the metal coordination, a hydrogen bond with HIS372, and the key interactions with PHE177, TYR181, LEU368, ILE406, ASN407, LEU414, PHE421, and LEU607, with the exception of contacts with LEU420 and HIS432 ( Figure 8B and 8D ).
Discussion
Pain is "an unpleasant sensory and emotional experience associated with actual or potential tissue damage" (Loeser and Treede, 2008) . Despite the rapid progresses in the development of several treatments of inflammatory pain, the efficacy and tolerability of conventional analgesics can be overshadowed by their unwanted side effects. The research on natural products, founded on their ethnopharmacological information, has provided significant contributions to drug improvement by the discovery of novel chemical structures and/or mechanism of actions in this respect (Rates, 2001; Maione et al., 2009; Maione et al., 2013; Maione et al., 2014; Zhao et al., 2014; Maione et al., 2015a) .
Along these lines, anti-inflammatory and analgesic characteristics of some members of the diterpenoid family have been described that may essentially interfere with the multiple signaling pathways that are deregulated during inflammation and inflammatory pain syndromes. Among these diterpenoids, much attention has been recently pointed on CS and CA that have been identified in leave extracts of different Salvia spp. (Senorans et al., 2000; Ramirez et al., 2006; Amici et al., 2014) . We started our study by assessing the effect of CS and CA on the modulation of Figure 8 3D models of CS (A) (coloured by atom types: C orange, O red, polar H white) and CA (B) (coloured by atom types: C yellow, O red, polar H white) in the binding site of 5-LOX. Residues in the active site are represented in tubes (coloured by atom types: C grey, N blue, O red, polar H white), and Fe ion is depicted as yellow cpk. 2D panels represent the interactions between CS (C), CA (D) and residues of the 5-LOX binding site. Negative charged residues are coloured in red, polar residues are coloured in light blue, and hydrophobic residues are coloured in green. The H-bond (side chain), metal coordination and salt bridge are indicated as dotted pink arrows, grey lines and blue/red lines respectively. Neutral histidine with hydrogen on the δ nitrogen is shown as HID, and neutral histidine with hydrogen on the ε nitrogen is shown as HIE.
peripheral inflammatory pain in a model of carrageenaninduced hyperalgesia in mice. This test is commonly used as an experimental animal model of acute inflammation, essentially regulated by mediators such as histamine, serotonin, bradykinin (in the first 2 h), and successively by prostaglandins (starting at 3 to 4 h) mainly released from neutrophils and macrophages (Morris, 2003; Rauf et al., 2015) . All these mediators detected at sites of inflammation orchestrate the inflammatory response by acting as vasodilators and hyperalgesic agents, and they simultaneously induce vascular permeability changes, erythema and oedema (Rackham and Ford-Hutchinson, 1983) . Moreover, their presence in the spinal cord and primary afferent neurons in pathological pain conditions has also been demonstrated (Noguchi and Okubo, 2011) . Importantly, the results from the carrageenan-induced paw hyperalgesia study demonstrate an anti-hyperalgesic effect of both diterpenoids at 4 h, which is likely attributed to the inhibition of eicosanoid production.
In order to confirm the analgesic properties of CS and CA, the formalin-induced pain test was employed. Formalin injection into the paw elicits a distinct biphasic nociceptive response. Centrally acting drugs such as opioids inhibit both early and late phases almost equally (Shibata et al., 1989) whereas nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, which are primarily acting in the periphery, only inhibit the late phase. The inhibitory effect of the diterpenoids in the second phase suggests a potential anti-inflammatory action (Muhammad et al., 2015) . Thus, the two diterpenoids primarily relieve the second phase (inflammatory pain), which suggests an interference with eicosanoid biosynthesis.
CS and CA have been reported to interfere with key signal transduction pathways of inflammation and cancer but only few direct molecular targets have been identified besides 5-LO and mPGES-1. For example, CS inhibits the activation of nuclear factor κB (IC 50 = 2.5-10 μM; (Lo et al., 2002) ), p38 mitogen-activated protein kinase (at 20 μM; (Lo et al., 2002) ), extracellular signal-regulated kinase (at 20 μM; (Lo et al., 2002) ), β-catenin (at 25 μM; (Moran et al., 2005) ), and intracellular Ca 2+ mobilization (IC 50 ≈ 30 μM; (Poeckel et al., 2008) ) and activates Nrf2 (EC 50 = 1-10 μM; (Martin et al., 2004) ), phosphatidylinositol-3-kinase/Akt (at 10 μM; (Martin et al., 2004) ), protein kinase C signaling (at 60 μM; (Subbaramaiah et al., 2002) ) and peroxisome proliferatoractivated receptor γ (EC 50 ≈ 40 μM; (Rau et al., 2006) ). Additionally, our in vitro results support the hypothesis that CS and CA could actually act by a mechanism related to the inhibition of PGE 2 biosynthesis in accordance with inhibition of COX-2 and leukocyte infiltration in inflamed tissues (Shibata et al., 1989; Mengoni et al., 2011; Zhao et al., 2015) . In fact, our present findings and previous data reveal that CS and CA interfere with key enzymes in eicosanoid formation, in particular with 5-LO (Laughton et al., 1991; Poeckel et al., 2008) , less prominent with mPGES-1 (Bauer et al., 2012) and to minor degree with COX enzymes (Laughton et al., 1991) . The superior potency of CS compared to CA seems to depend on differences in the 5-LO binding affinity rather than in compound stability because CS is considered more stable than CA (Zhang et al., 2012) . The impact of cellular metabolism on the concentration of CS and CA remains unclear.
On this basis, we investigated how the multi-target drugs CS and CA modulate the eicosanoid profile of activated human neutrophils and monocytes. Both compounds suppressed the formation of a wide range of 5-LO-and COX-derived lipid mediators. Excessive redirections as previously described for COX and mPGES-1 inhibitors were not observed within the eicosanoid network (Koeberle and Werz, 2015) . The superior selectivity for 5-LO and mPGES-1 compared to COX, 12-and 15-LO rather precludes general effects of CS and CA on substrate supply or upstream signaling pathways such as LPS signal transduction. So far, our results strongly suggest that 5-LO and mPGES-1 and potentially 12-and 15-LO represent relevant targets of CS and CA with impact on the eicosanoid network of primary innate immune cells. Moreover, in intact cells, the two diterpenoids seem to interfere to a considerable extent with COX activity, despite their failure to suppress isolated bovine COX-1 and human recombinant COX-2 in cell-free assays (Bauer et al., 2012) , either by direct enzyme inhibition in the cellular context or by diminished enzyme expression. In fact, both CS and CA have been reported to inhibit the activation of NF-κB (Lo et al., 2002) , (Yu et al., 2008) , a critical transcription factor regulating the expression of inducible COX-2 and mPGES-1. Of interest, 5-, 12-and/or 15-LO activities are required for the biosynthesis of specialized pro-resolving lipid mediators including resolvins, protectins and maresins (SPMs) (Serhan, 2014) . The effect of CS and CA on the generation of SPMs remains elusive in light of the complex and partly opposing effects of CS and CA on the formation of 12-and 15-LO products depending on lipid species, cell type and experimental condition. However, it is likely that also SPM biosynthesis is profoundly regulated by CS and CA with potential consequence for the resolution of inflammation. By molecular docking, we have characterized the interaction of CS and CA with mPGES-1 and 5-LO (Poeckel et al., 2008; Emami et al., 2013) . Dual inhibitors that block both mPGES-1 and 5-LOX within arachidonic acid metabolic pathways are expected to possess clinical advantages over selective inhibitors of COX enzymes (Thoren et al., 2003; Samuelsson et al., 2007; Koeberle and Werz, 2014; Koeberle and Werz, 2015) . For these reasons, the detailed analysis of the eicosanoid network together with contextual docking analysis on mPGES-1 and 5-LOX has represented a crucial step in the structural part of our study. Relating to mPGES-1, we have analyzed the binding of CS and CA in the mPGES-1 binding site in presence of the cofactor glutathione (GSH) (Sjogren et al., 2013; Li et al., 2014; Luz et al., 2015) . An accurate analysis of the main interactions of compounds in the active site allows the rationalization of their activity (Sjogren et al., 2013; Li et al., 2014; Chini et al., 2015; Iranshahi et al., 2015; Luz et al., 2015; Terracciano et al., 2015) . In particular, CS and CA are accommodated in the pocket situated in the region at the interface of the two mPGES-1 subunits, establishing good interactions with the receptor counterpart. All the established interactions corroborate the comparable antagonist activity of both diterpenoids, in agreement with the experimental biological inhibition reported by Bauer et al. (2012) , and their response to inflammatory pain reported above. Regarding 5-LO, the induced fit docking approach was used to simulate and to study the interactions between 5-LO and CS or CA with residues belonging to the active site close to the catalytic iron (Gilbert et al., 2011) . These molecular results seem to be in accordance with the observed activity of the two diterpenoids on human recombinant enzyme and in activated human primary neutrophils.
Conclusions
In vivo evidences, molecular docking studies and eicosanoid profiling provide a mechanistic basis for the anti-nociceptive effects of CS and CA associated with inflammatory pain. Our biological evaluation as well as the in silico data clearly show that CS and CA act on mPGES-1 and 5-LO leading to suppression of pro-inflammatory eicosanoid formation. These conclusions render CS and CA interesting bioactive ingredients in Salvia spp. that are traditionally used as anti-inflammatory remedies and paving the way for a rational use of Salvia spp. nutraceuticals. Figure S1 Effect of CS and CA on eicosanoid formation in activated human neutrophils (A) and monocytes (B). A, Neutrophils were pre-incubated with vehicle (DMSO) or test compounds for 10 min before eicosanoid formation was initiated by A23187 (2.5 μM). B, Monocytes were pre-incubated with vehicle (DMSO) or test items and then stimulated with LPS for 24 h. Data are given as mean ± SEM. of single determinations obtained in three (A) and five (B) independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs.versus vehicle control; ANOVA + Tukey HSD post hoc tests. Figure S2 3D models of CS (coloured by atom types: C orange, O red, polar H white) and CA (coloured by atom types: C yellow, O red, polar H white) in the binding site of 12-LOX. Figure S3 2D panels represent the interactions between CS (A), CA (B) and residues of the 12-LO binding site. Negative charged residues are coloured in red, polar residues are coloured in light blue, hydrophobic residues are coloured in green. The H-bond (side chain), metal coordination and salt bridge are indicated as dotted pink arrows, grey lines, and blue/red lines respectively. Figure S4 3D models of CS (coloured by atom types: C orange, O red, polar H white) and CA (coloured by atom types: C yellow, O red, polar H white) in the binding site of 15-LOX. Figure S5 2D panels represent the interactions between CS (A), CA (B) and residues of the 15-LOX binding site. Negative charged residues are coloured in red, polar residues are coloured in light blue, hydrophobic residues are coloured in green. The H-bond (side chain), metal coordination and salt bridge are indicated as dotted pink arrows, grey lines, and blue/red lines respectively.
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